Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 28 for “"GeneXpert"”.
-
Clinical factors associated with negative GeneXpert Ultra results among adults with pulmonary TB disease
Abstract Background: Xpert MTB/RIF Ultra is a sputum diagnostic test for pulmonary tuberculosis (TB) disease, but false negative results may occur. Understanding the characteristics associated with Ultra-negative pulmonary TB disease (UN-PTB) can minimize risks of missed or delayed diagnosis in TB …
-
Detection of Genetic Thrombophilia (Fa V Leiden & PT20210 mutation) using GeneXpert Technology with IQCP Implementation
… management.</p> <p>The introduction of the GeneXpert technology by Cepheid will aid in the prevention of staff injury from repetitive motion, improve the turnaround time and eliminate potential risk of error. This test system performs DNA isolation, amplification and detection within a …
-
Effects of GeneXpert MTB/RIF Testing and GxAlert eHealth Platforms on MDR-TB Diagnosis and Linkage to Care in Sofala Province, Mozambique
… rates and linkage to care, we installed three GeneXpert MTB/RIF machines in Sofala Province starting in 2012 and installed an eHealth platform called GxAlert in 2014. Methods: We conducted a retrospective clinical review using routine clinical data from GeneXpert MTB/RIF assays (Xpert), and the …
-
Factores de riesgo asociados a tener tuberculosis entre personas con síntomas respiratorios agudos en la Jurisdicción de la DIRIS Lima Norte entre abril del 2020 a julio del 2022
… Optimizar el uso de pruebas moleculares como el GeneXpert resulta esencial para mejorar la identificación temprana de la enfermedad. El objetivo de este estudio fue identificar los factores asociados a TB en personas con síntomas respiratorios agudos en la jurisdicción de la DIRIS Lima Norte. Se …
-
Non-invasive diagnosis of pediatric tuberculosis
… from 20 adult TB cases confirmed by Cepheid’s GeneXpert (PCR) analysis of sputum. Eighteen of these subjects yielded swabs that were positive for Mycobacterium tuberculosis (MTB) DNA in a manual quantitative PCR (qPCR) analysis. Control samples from 20 healthy adults were 100% negative. The …
-
DYNAMIC MODELLING OF NEXT GENERATION SEQUENCING (NGS) AS A DIAGNOSTIC TOOL FOR DRUG-RESISTANT TUBERCULOSIS IN HIGH-BURDEN SETTINGS: A COST EFFECTIVENESS ANALYSIS
… targeted Next-Generation Sequencing (tNGS) and GeneXpert XDR are available for DR-TB diagnosis. The objective of this study is to determine the health and economic impact of implementing these new diagnostic tools in high TB-burden settings. Methods: A dynamic simulation model was calibrated to …
-
Avaliação de ensaios comerciais de RT-qPCR para monitoramento de doença residual mínima em pacientes com leucemia mielóide crônica
… para monitoramento de BCR-ABL1 na LMC: GeneXpert® BCR-ABL Assay (Cepheid), Ipsogen® BCR-ABL1 Mbcr Fusion Quant Kit (QIAGEN), BCR-ABL1 Quant RUO™ Assay (Asuragen), LightCycler® t(9;22) Quantification Kit (Roche Molecular Biochemicals) e ODK-1201 (Otsuka Pharmaceutical Co. Ltd.). …
-
Evaluation of two Fingerstick blood Point-of-Care Triage Test for Active TB
… 100ul of FSB was analysed using the Cepheid GeneXpert MTB-HR prototype, while for the MBT, 10ul whole blood or 20ul lysed blood was analysed using the up-converting phosphor (UCP) lateral flow technology. The accuracy of both tests was determined in relation to GeneXpert Ultra and a …
-
Ταυτοποίηση και έλεγχος ευαισθησίας μη φυματιωδών και φυματιωδών μυκοβακτηρίων με μοριακές μεθόδους
… Assay (LPA) και, σε επιλεγμένα δείγματα, του GeneXpert MTB/RIF, που χρησιμοποιούνται για τη διάγνωση λοιμώξεων από μυκοβακτηρίδια, καθώς και να αναλύσει αναδρομικά τα εργαστηριακά δεδομένα της περιόδου 2016-2024 με σκοπό την αποτύπωση της εξέλιξης των ετήσιων ποσοστών θετικότητας και των …
-
Field deployable low cost microfluidic system for real-time isothermal detection of drug resistant tuberculosis
… costing ~$90,000 for equipment (e.g., GeneXpert®), $20-$50 per test, and well-trained technicians. None of these resources are adequate in developing nations. Our group has developed an inexpensive genetic analysis platform, named Gene-ZTM at a manufacturing cost of $500, which has the …
-
The molecular diagnosis of sexually transmissible infections at the point-of-care in remote Australia and Papua New Guinea
… The first compared the performance of the Genexpert CT/NG molecular point of care (POC) assay against a widely used laboratory assay for use with anorectal samples in PNG. The second assessed the feasibility of implementing new STI POC assays for same day testing and treatment of women …
-
Improving Diagnosis and Understanding the Pathophysiology of Tuberculous Meningitis
… evaluation of the diagnostic performance of GeneXpert MTB/RIF (Xpert) against GeneXpert MTB/RIF Ultra (Ultra) in 205 individuals with TBM. Diagnostic sensitivities of Ultra and Xpert against a clinical TBM reference standard were 47.2% (25/53, 95% confidence interval [CI] 34.4-60.3%) and …
-
Innovative approaches for cervical cancer screening in Papua New Guinea: Evaluation of novel point-of-care test and treat algorithms in a high-burden setting
… A significant development has been the GeneXpert HPV Test (Xpert HPV: Cepheid, Sunnyvale, CA); an easy-to-use, rapid (60 minutes), highly accurate HPV test that can be offered at point of care (POC) to inform clinical management. A prospective study was undertaken in Goroka and Mt Hagen, …
-
Comparison of Clinical Features Between Inpatient and Outpatient Cases of Clostridium difficile Infection
… Instead, both laboratories use the Cepheid GeneXpert C. diffcile assay to rapidly detect the toxin B gene (tcdB). These two different test methods and the testing requirements provided an opportunity to compare clinical features of patients whom CDI was detected by targeted testing to those …
-
A Comprehensive Revision of Tuberculosis Epidemiology and Control Program in Abu Dhabi
… database was used to evaluate the benefits of GeneXpert in screening settings. Finally, a comprehensive review and evaluation of the program, using a WHO framework for evaluation of a TB control program, was used to understand the advantages of the program and offer recommendations for program …
-
Mycobacterium tuberculosis DNA detection on tongue swabs: Effect of anti-tuberculosis drug treatment
… Sputa were also collected and tested by Cepheid GeneXpert MTB/RIF Ultra (Xpert Ultra) and mycobacteriological culture. Treatment was effective in all patients as determined by sputum culture and clinical outcomes. MTB DNA was extracted from swabs and concentrated by ethanol precipitation. MTB DNA …
-
Tuberculosis case finding and performance of symptom screening and rapid diagnostic tests in HIV-infected pregnant women in western Kenya
… bacilli (AFB), mycobacterial liquid culture, GeneXpert MTB/RIF (Xpert), urine lipoarabinomannan (LAM), and tuberculin skin testing (TST) were performed. We determined prevalence and correlates of culture-confirmed pulmonary TB, and compared diagnostic performance of World Health Organization …
-
Oral swab PCR as an alternative to sputum-based methods for diagnosis of pulmonary tuberculosis
… from 20 HIV-negative subjects with active, (GeneXpert-confirmed) pulmonary tuberculosis, and from 55 healthy, unexposed controls. To detect MTB, the oral swab samples were tested using an in-house polymerase chain reaction (PCR) protocol targeting the IS6110 insertion element, which is unique …
-
Diagnostic performance, acceptability, and implementation of caregiver-collected oropharyngeal nasal (ON) swabs for molecular detection of respiratory pathogens in symptomatic children
… tested using the SARS-CoV-2/Influenza A+B/RSV GeneXpert® assay and a subset were tested on the BioFire® Respiratory Panel (RP) 2.1 during the initial research phase. In a subsequent implementation phase during a period of increased M. pneumoniae incidence, paired ON and NP swabs were collected …
-
On the Optimization of Clostridioides difficile Diagnostics Through RT-PCR Cycle Threshold Defined Zones of Disease Probability
… test platforms delineated CDI probability zones: GeneXpert®: 24.00, 33.61; Simplexa®: 28.97, 36.85; Elite MGB®: 30.18, 37.43; and BD Max™: 27.60, 34.26. A prospective cohort study was conducted to investigate if these zones can be further correlated to indicators of severe CDI. Primary diagnosis, …
Page 1 of 2